2024 Conference Coverage
Playback speed
10 seconds
MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide
174 views
April 25, 2024
Login to view comments.
Click here to Login